LCID
Lucid Group, Inc.
LCID offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
LEGH
Legacy Housing Corporation
LEGH has a slight edge over LCID overall, supported by stronger fundamentals and lower modeled downside.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
LEGH Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
LEGH's revenue, profitability, cash flow and balance sheet are all currently strong.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
LEGH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.2x | $21.99 | -23% |
| Fair | 11x | $28.70 | +1.1% |
| Current | 11x | $28.38 | — |
| Expensive | 13x | $33.71 | +19% |
| Forward | 14x | $28.38 | — |
Historical ranges are pointers, not guarantees.
LEGH's PE is in its fair range at 11x. Analysts expect earnings to fall, which would put today's price at 14x next year's earnings, in its expensive range.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
LEGH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Decline | |
| Decline | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect LEGH's earnings and revenue to decline, with profitability weakening.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
LEGH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.07 | -23% |
| Q3 2026 | $2.68 | +37% |
| Q2 2026 | $2.18 | -2.7% |
| Q1 2026 | $1.79 | -22% |
| Q4 2025 | $1.74 | -30% |
| Q3 2025 | $1.95 | -10% |
| Q2 2025 | $2.24 | +3.2% |
| Q1 2025 | $2.29 | +8% |
| Q4 2024 | $2.48 | +14% |
LEGH has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over LEGH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
LEGH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $69.7M | +72% |
| Q2 2026 | $66.3M | +32% |
| Q1 2026 | $34.4M | -3.7% |
| Q4 2025 | $38.3M | -29% |
| Q3 2025 | $40.5M | -8.6% |
| Q2 2025 | $50.2M | +18% |
| Q1 2025 | $35.7M | -18% |
| Q4 2024 | $54.2M | +61% |
LEGH's revenue is growing: $70M last quarter, up 72% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | +9.6 points |
| Q2 2026 | 40% | +6.4 points |
| Q1 2026 | 36% | +3.5 points |
| Q4 2025 | 27% | -1.7 points |
| Q3 2025 | 24% | -11 points |
| Q2 2025 | 34% | -4.2 points |
| Q1 2025 | 33% | -6.2 points |
| Q4 2024 | 29% | -0.2 points |
LEGH has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
LEGH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $7.4M | +45% |
| Q2 2026 | $12.3M | +235% |
| Q1 2026 | $5.4M | +49% |
| Q4 2025 | $15.7M | +161% |
| Q3 2025 | $5.1M | -44% |
| Q2 2025 | $3.7M | +114% |
| Q1 2025 | $3.6M | -63% |
| Q4 2024 | $6M | +$17.4M |
LEGH has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
LEGH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -29.6K shares |
| 1 year | -2.7% | -649K shares |
| 3 years | -5.3% | -1.3M shares |
| 5 years | -2.1% | -499K shares |
| Available history | -2.7% | -653K shares |
LEGH has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $93,000 |
| Q1 2026 | $573,000 |
| Q4 2025 | $1.1M |
| Q3 2025 | $1,000 |
| Q2 2025 | $5.8M |
| Q1 2025 | $675,000 |
| Q4 2024 | — |
LEGH spent $2M buying back its own shares over the past year, down 73% from the year before.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LEGH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.2x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q3 2024 | 0.0x | Very low |
| Q2 2024 | 0.2x | Very low |
| Q1 2024 | 0.2x | Very low |
LEGH has more cash than debt.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
LEGH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.6 | Neutral |
| Stochastic | 35.9 | Neutral |
LEGH's weekly RSI is 58 (neutral) and its Stochastic is 36 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
LEGH PE vs Consumer Cyclical Sector
| Metric | LEGH | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 18x | 41% below |
| PE % | 47 | 47 | Same percentile |
LEGH is trading at 11x earnings, a 41% discount to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
LEGH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $28.6 | 0.8% below |
| 20 week MA | $28.0 | 1.2% above |
| 50 week MA | $24.2 | 17% above |
| 100 week MA | $24.2 | 17% above |
| 200 week MA | $23.6 | 20% above |
LEGH has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
LEGH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.8 | $14.9 | -11% |
| 2021 | $14.9 | $25.8 | +74% |
| 2022 | $25.8 | $17.8 | -31% |
| 2023 | $17.8 | $25.2 | +41% |
| 2024 | $25.2 | $24.8 | -1.7% |
| 2025 | $24.8 | $19.8 | -20% |
| 2026 YTD | $19.8 | $28.4 | +43% |
LEGH has the edge over LCID on returns for 2026, with the stronger performance.